CLChristopher Lin

Christopher Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher Lin has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Human Gait Circuit Derived from Brain Lesions and Deep Brain Stimulation

    by Lan Luo, Frederic L.W.V.J. Schaper, Michael Nguyen, Sandrine Jabbour, Joey Hsu, Louis Soussand, Christopher Lin, Shan H Siddiqi, Konstantin Butenko, Andreas Horn, et al.

    Objectives: The relevant neuroanatomy for gait dysfunction remains unclear. We sought 1) to identify a brain circuit for gait impairment post stroke, 2) to identify a brain circuit for gait changes after subthalamic DBS for Parkinson′s disease, 3) to test for convergence between these two circuits. Methods: This cross-sectional retrospective study used data from four independent datasets including 109 individuals with stroke and 125 patients with PD who received subthalamic DBS. Gait impairment post stroke was measured using the Combined Walking Index. Gait changes after subthalamic DBS was measured using the gait subscore on the UPDRS Part III. Connectivity between lesion locations or DBS sites and two a priori locomotor regions was computed using a large normative connectome. We repeated this analysis in a data-driven fashion to identify additional connections. Results: Connectivity between lesion locations and a priori regions in the pedunculopontine nucleus and cerebellar locomotor region were associated with gait impairment post stroke ( p < 0.05), along with connectivity to a distributed circuit of other brain regions. Connectivity between DBS sites and our a priori gait regions and connectivity between DBS sites and our lesion-based gait circuit were all associated with gait changes post DBS ( p < 10-3). Data-driven gait circuits derived from lesions and DBS showed similar topography and converged on a common brain circuit (spatial r = 0.68, p = 0.0063, 10000 permutations). Interpretation: Lesion locations impairing gait and DBS sites modulating gait converge on a common brain circuit, which may provide a neuromodulation target for gait dysfunction.

  • Open Access

    An anorexia nervosa network derived from human brain lesions

    by Frederic Schaper, Joseph Taylor, Eve Cohen, Christopher Lin, Ona Wu, Natalia Rost, Kristin Javaras, Michael Fox

  • Top Cited Papers

    A transdiagnostic network for psychiatric illness derived from atrophy and lesions

    by Joseph J. Taylor, Christopher Lin, Daniel Talmasov, Michael A. Ferguson, Frederic L. W. V. J. Schaper, Jing Jiang, Madeleine Goodkind, Jordan Grafman, Amit Etkin, Shan H. Siddiqi, et al.

    Psychiatric disorders share neurobiology and frequently co-occur. This neurobiological and clinical overlap highlights opportunities for transdiagnostic treatments. In this study, we used coordinate and lesion network mapping to test for a shared brain network across psychiatric disorders. In our meta-analysis of 193 studies, atrophy coordinates across six psychiatric disorders mapped to a common brain network defined by positive connectivity to anterior cingulate and insula, and by negative connectivity to posterior parietal and lateral occipital cortex. This network was robust to leave-one-diagnosis-out cross-validation and specific to atrophy coordinates from psychiatric versus neurodegenerative disorders (72 studies). In 194 patients with penetrating head trauma, lesion damage to this network correlated with the number of post-lesion psychiatric diagnoses. Neurosurgical ablation targets for psychiatric illness (four targets) also aligned with the network. This convergent brain network for psychiatric illness may partially explain high rates of psychiatric comorbidity and could highlight neuromodulation targets for patients with more than one psychiatric disorder.


  • Baclofen-induced sexual dysfunction

    by Matthew McGehee, Joseph E. Hornyak, Christopher Lin, Brian M. Kelly

    Baclofen, a γ-aminobutyric acid B (GABA-B) agonist, is commonly used to treat spasticity associated with the upper motor neuron syndrome. Sexual dysfunction has been reported in men using intrathecal baclofen1 but has not been reported with oral baclofen use or in women. We present three cases of sexual dysfunction induced by oral baclofen. Case 1 is a 25-year-old woman with spastic diplegic cerebral palsy who was having increasing functional problems. She had never been treated with medication for her spasticity. She was started on baclofen, 10 mg nightly, titrating the dose up to 10 mg four times a day (QID) over 4 weeks. At follow-up, she was taking 10 mg three times daily (TID), as QID dosing caused fatigue. She noted improvements in tone and function but also noted a new difficulty in attaining orgasm as well as decreased intensity of orgasm. (She denied prior sexual dysfunction.) Orgasm could be reached, but additional …